Retatrutide 10mg
99.4% HPLC PurityA triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.
A$129.99AUD
Retatrutide 30mg
SKU: PW-026 • Batch: PW-260301
99.4% HPLC PurityCOA Verified ✓
Our highest-strength Retatrutide vial — the same 99.4%-pure triple GLP-1/GIP/glucagon agonist, at three times the mass of the 10mg format for extended protocols.
Read the full description ↓A$289.99AUD
Price includes GST
In Stock: Next-Day Dispatch
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
Frequently Bought Together
Retatrutide 20mg
99.4% HPLC PurityThe same triple receptor agonist as our 10mg vial, supplied at double the strength.
A$219.99AUD
Retatrutide — Bulk Raw Material
99.4% HPLC PurityThe same Retatrutide powder as our vials, sold by the gram for larger research programs.
A$200.00AUD/ gram
Key Research Features
- Triple the mass of the 10mg vial in a single unit
- Triple receptor agonist: GLP-1, GIP, and glucagon
- 99.4% HPLC purity (independently verified)
- Full COA with mass spectrometry confirmation
- LAL endotoxin tested (<1.0 EU/mg)
- Manufactured in Australia
Molecular Details
- Sequence
- LY3437943 (proprietary triple receptor agonist sequence; see COA for full data)
- Molecular Formula
- C₂₄₉H₃₉₆N₆₈O₇₂
- CAS Number
- 2381089-83-2
- Molecular Weight
- ~5766 Da
- Purity
- 99.4%
- Form
- Lyophilised powder
- Appearance
- White/off-white lyophilised powder
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Usage & Storage
- Quantity
- 30mg / vial
- Dosage Notes
- Research protocols explore GLP-1/GIP/Glucagon receptor agonist activity at varying concentrations. Consult published clinical literature for specific study designs.
- Reconstitution
- Reconstitute with 3–6mL bacteriostatic water. Swirl gently; do not shake. Allow to fully dissolve before use.
- Injection Route
- Subcutaneous (research protocols)
- Storage Temp
- −20°C for long-term storage
- Storage Conditions
- Store lyophilised at −20°C, protected from light. After reconstitution, refrigerate at 2–8°C and use within 4 weeks.
- Packaging
- Sterile, tamper-evident research vial
Description
Retatrutide (LY3437943) is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This is our highest-strength vial at 30mg, supplied as a lyophilised powder at 99.4% HPLC purity with full Certificate of Analysis (COA) documentation.
The material is identical to our 10mg and 20mg vials — same Australian manufacturing, same chain-of-custody documentation, same independent third-party HPLC testing, mass spectrometry identity confirmation, LAL endotoxin assay (<1.0 EU/mg), and sterility screening before dispatch. The only difference is the mass in the vial.
The 30mg format suits extended research programs and larger sample counts, where fewer vials means fewer reconstitution steps, less packaging per milligram, and fewer handling points across a protocol.
Research & Guides
Frequently Asked Questions: Retatrutide 30mg
Only in the mass per vial. All three are the same research-grade Retatrutide (LY3437943) at 99.4% HPLC purity from the same Australian production run, with the same COA testing. The 30mg vial simply contains three times as much material as the 10mg.
Add 3–6mL of bacteriostatic water slowly to the vial. Gently swirl; do not shake. Allow the lyophilised powder to dissolve completely before use in research protocols.
Store lyophilised at −20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Yes. Every batch ships with a downloadable COA including HPLC purity percentage, mass spectrometry identity confirmation, sterility results, and LAL endotoxin assay data.
Research Use Only: Important Disclaimer
Retatrutide 30mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
Reviews
Questions & Answers
No questions yet — be the first to ask about this product.